Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Misao Owada"'
Autor:
Toshihiro Ohura, Masaki Takayanagi, Fumio Endo, Masafumi Matuo, Yoichi Matsubara, Torayuki Okuyama, Yoshiyuki Okano, Kimitoshi Nakamura, Haruo Shintaku, Hiroyuki Ida, Makoto Yoshino, Tetsuya Ito, Shigeo Kure, Misao Owada
Publikováno v:
Pediatrics international : official journal of the Japan Pediatric SocietyReferences. 63(1)
Importance Sapropterin hydrochloride, a natural coenzyme (6R-tetrahydrobiopterin) of phenylalanine hydroxylase, was first approved as a treatment for tetrahydrobiopterin deficiency in 1992 in Japan, and was then approved as a treatment for a tetrahyd
Autor:
Teruo Kitagawa, Misao Owada
Publikováno v:
Journal of The Society of Japanese Women Scientists. 12:22-31
Autor:
Naoko Kakee, Fumiki Hirahara, Hozo Umehashi, Chieko Fujii, Shohei Harada, Yuki Sato, Makoto Yoshino, Yan Hong Gu, Haruo Shintaku, Tadaaki Kato, Misao Owada
Publikováno v:
Pediatrics International. 52:393-397
Background: Residual dried blood spots (DBS) remaining after routine newborn screening (NBS) tests are candidate specimens for extended uses such as quality assurance and the development of new technology. A trial of NBS using tandem mass-spectrometr
Autor:
Toya Ohashi, Masahisa Kobayashi, Akemi Tanaka, Yoshikatsu Eto, Hideo Odaka, Nobuyuki Ishige, Teruo Kitagawa, Ken Suzuki, Misao Owada
Publikováno v:
Pediatric Nephrology. 23:1461-1471
The most appropriate time for screening for Fabry disease (FD) is school age. For this reason, we developed non-invasive methods for measuring urinary alpha-galactosidase A (alpha-gal A) protein, using enzyme-linked immunosorbent assay (ELISA), and f
Autor:
Tatsuhiko Urakami, Kensuke Harada, Misao Owada, Shigeo Morimoto, Teruo Kitagawa, Yoshikazu Nitadori
Publikováno v:
Clinical Pediatric Endocrinology
This study evaluated recent changes in the annual incidence of childhood type 2 diabetes in the Tokyo metropolitan area. From 1974 to 2004, a total of 236 students were diagnosed as having type 2 diabetes by the urine glucose screening program at sch
Autor:
Teruo Kitagawa, Kensuke Harada, Misao Owada, Tatsuhiko Urakami, Shigeo Morimoto, Yoshikazu Nitadori
Publikováno v:
Pediatric Research. 61:141-145
A large number of children with type 2 diabetes have been detected by a urine glucose screening program conducted at schools in Japan since 1975. The incidence of type 2 diabetes in children has increased over the last three decades, and the incidenc
Publikováno v:
Pediatrics International. 47:430-433
BACKGROUND The aim of this study was to evaluate the effect of metformin in addition to insulin therapy in adolescents and young adults with type 1 diabetes mellitus. METHODS Nine patients, two males and seven females, aged 18.1 +/- 3.0 years, with t
Autor:
Nobuyuki Ishige, Masahisa Kobayashi, Teruo Kitagawa, Akemi Tanaka, Toya Ohashi, Yoshikatsu Eto, Ken Suzuki, Bryan Winchester, Misao Owada, Kevin Mills, Joan Keutzer
Publikováno v:
Molecular Genetics and Metabolism. 85:196-202
Fabry disease is an X-linked sphingolipidosis due to a deficiency of c alpha-galactosidase A, which leads to the accumulation of globotriaosyleeramide (GL-3) in several organs. When recombinant human alpha-galactosidase A is intravenously administere
Publikováno v:
Diabetes Research and Clinical Practice. 68:96-103
The aim of the study was to examine the optimal use of quick-acting insulin analogue (Q) switching from regular insulin (R) in combination with basal insulin and its long-term effects in 40 Japanese children and adolescents with type 1 diabetes. Insu
Autor:
Masako Fujiwara, Tatsuo Hosoya, Yoshiyuki Suzuki, Yasunori Utsunomiya, Hirohisa Saito, Teruo Kitagawa, Koji Inui, Seibu Mochizuki, Hitoshi Sakuraba, Atsushi Mizuno, Yoshikatsu Eto, Misao Owada, T. Ohashi, Makio Kawakami, Norio Sakai
Publikováno v:
Journal of Inherited Metabolic Disease. 28:575-583
Fabry Disease (alpha-galactosidase A deficiency) is an X-linked hereditary disorder leading to the pathological accumulation of globotriaosylceramide (GL-3) in lysosomes, particularly in the vascular endothelium of the kidney, heart and brain. We rep